Immunity and immunopathology to viruses: what decides the outcome?

BT Rouse, S Sehrawat - Nature Reviews Immunology, 2010 - nature.com
Many viruses infect humans and most are controlled satisfactorily by the immune system
with limited damage to host tissues. Some viruses, however, do cause overt damage to the …

Galectin-9 as a biomarker of disease severity

P Moar, R Tandon - Cellular immunology, 2021 - Elsevier
Abstract Galectin-9 (Gal-9) is a β-galactoside binding lectin known for its immunomodulatory
role in various microbial infections. Gal-9 is expressed in all organ systems and localized in …

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

R Yang, L Sun, CF Li, YH Wang, J Yao, H Li… - Nature …, 2021 - nature.com
The two T cell inhibitory receptors PD-1 and TIM-3 are co-expressed during exhausted T cell
differentiation, and recent evidence suggests that their crosstalk regulates T cell exhaustion …

The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy

S Kandel, P Adhikary, G Li, K Cheng - Cancer letters, 2021 - Elsevier
Immune checkpoint blockade has shown unprecedented and durable clinical response in a
wide range of cancers. T cell immunoglobulin and mucin domain 3 (TIM3) is an inhibitory …

Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation

B Bengsch, B Martin, R Thimme - Journal of hepatology, 2014 - Elsevier
Background & Aims The upregulation of several inhibitory signalling pathways by exhausted
HBV-specific CD8+ T cells in chronic infection is thought to contribute to viral persistence …

Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells

C Wu, T Thalhamer, RF Franca, S Xiao, C Wang… - Immunity, 2014 - cell.com
The β-galactoside-binding protein galectin-9 is critical in regulating the immune response,
but the mechanism by which it functions remains unclear. We have demonstrated that …

Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators

I Le Mercier, JL Lines, RJ Noelle - Frontiers in immunology, 2015 - frontiersin.org
In the last two years, clinical trials with blocking antibodies to the negative checkpoint
regulators CTLA-4 and PD-1 have rekindled the hope for cancer immunotherapy. Multiple …

T cell exhaustion: from pathophysiological basics to tumor immunotherapy

K Catakovic, E Klieser, D Neureiter… - Cell Communication and …, 2017 - Springer
The immune system is capable of distinguishing between danger-and non-danger signals,
thus inducing either an appropriate immune response against pathogens and cancer or …

Role of regulatory T cells during virus infection

T Veiga‐Parga, S Sehrawat… - Immunological reviews, 2013 - Wiley Online Library
The host response to viruses includes multiple cell types that have regulatory function. Most
information focuses on CD 4+ regulatory T cells that express the transcription factor Foxp3+ …

Emerging Tim-3 functions in antimicrobial and tumor immunity

K Sakuishi, P Jayaraman, SM Behar, AC Anderson… - Trends in …, 2011 - cell.com
T cell immunoglobulin-3 (Tim-3) has been identified as a marker of differentiated interferon-γ-
producing CD4+ T helper type 1 and CD8+ T cytotoxic type 1 cells. The interaction of Tim-3 …